We study how metabolic processes control cancer cell identity, plasticity, and metastasis.
Our research focuses on how metabolites and ER redox balance regulate signaling pathways such as STAT3, EMT, and ferroptosis sensitivity, with the goal of identifying new therapeutic vulnerabilities in aggressive cancers.